Showing results (61-70 of 163) with videos related to
Sort By:
Pageof 17
Gynecologic Oncology|November 7, 2000
Laparoscopic port-site recurrence following surgery for a stage IB squamous cell carcinoma of the cervix with negative lymph nodesP D Kohlberger, L Edwards, C Collins, et al.Obstetrics and Gynecology|August 1, 1987
Current therapy for dysgerminoma of the ovaryG M Thomas, A J Dembo, N F Hacker, et al.Obstetrics and Gynecology|January 1, 1982
Levator ani transposition for anal incompetence secondary to sphincter damageJ S Berek, L D Lagasse, N F Hacker, et al.Current Problems in Cancer|March 1, 1988
Uterine corpus and cervical cancerJ S Berek, N F Hacker, K D Hatch, et al.Cancer|August 5, 2000
Conservative surgery to preserve ovarian function in patients with malignant ovarian germ cell tumors. A review of 74 casesJ J Low, L C Perrin, A J Crandon, et al.The Australian & New Zealand Journal of Obstetrics & Gynaecology|May 1, 1982
Positive peritoneal cytology in corpus carcinoma. Report of a fatal outcomeN F Hacker, T W Castaldok, C P Morrow, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 14, 2004
Malignant perivascular epithelioid cell tumor (PEComa) arising in the broad ligamentD Fink, D E Marsden, L Edwards, et al.Journal of Embryology and Experimental Morphology|June 1, 1976
Quantitation of the spatial distribution of 'prespore vacuoles' in pseudoplasmodia of Dictyostelium discoideumP A Farnsworth, W F LoomisPathology|July 1, 1994
The value of Medicare statistics in monitoring Pap smear screening. Screening versus non-screening smears: the role of the laboratoryC Laverty, J Thurloe, A FarnsworthOncogenesis|May 31, 2016
Migration and invasion is inhibited by silencing ROR1 and ROR2 in chemoresistant ovarian cancerC E Henry, E Llamosas, A Djordjevic, et al.Pageof 17